LinkedIn facebook twitter youtube
News archive

Myeloma Patient Europe (MPE) has been aware of the lack of clinical trials opening in many Central and Eastern European (CEE) countries, as well as inequalities in access with CEE countries for participating in ongoing trials. To gather data on, and further understand the access situation, MPE conducted research on barriers and facilitators to clinical trials, with a specific focus on CEE countries. The research was completed under the guidance of MPE members from across the region through its CEE workgroup.


Join MPE in our online event on the 29th of November 2022 from 15:00-16:30 CET, where we will present the research findings, hear the perspectives of CEE patient advocates and clinicians, and discuss recommendations to improve access to clinical trials in Central and Eastern European countries. Click here to register for the webinar.


Recent news

» Myeloma Patients Europe report finds huge inequalities in access to myeloma clinical trials in Central and Eastern Europe

» Horizon Europe research project looks to improve the affordability and sustainability of innovative health technologies

Leave a Reply

Your email address will not be published.

I accept the Privacy Policy